Coagulation in liver surgery: an observational haemostatic profile and thromboelastography study.


Journal

ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634

Informations de publication

Date de publication:
06 2020
Historique:
received: 11 12 2019
revised: 13 03 2020
accepted: 02 04 2020
pubmed: 27 5 2020
medline: 30 4 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

International normalized ratio (INR) is used as a marker of the haemostatic status following liver resection. However, the impact of liver resection on haemostasis is complex and beyond what can be measured by INR. This study aimed to prospectively assess haemostatic profile following liver resection and determine if INR measurement can safely guide post-operative thromboprophylaxis. In this prospective cohort study, patients undergoing liver resection had coagulation parameters (International normalised ratio (INR), prothrombin time (PT), activated partial thromboplastin time, fibrinogen, d-dimer, von Willebrand factor antigen, procoagulant activity of phospholipids and clotting factors II, VII, VIIIc, IX and X) and thromboelastogram parameters assessed perioperatively. Clinical follow-up assessed for thromboembolism and haemorrhage. In the 41 patients included, INR was significantly (P < 0.0001) elevated post-operatively, and INR >1.5 was observed in seven of 41 (17.1%) on post-operative day 1 and one of 41 (2.4%) patients on post-operative day 3, respectively. Factor VII levels showed transient reduction but other factors, especially factors II and X, remained within normal range following liver resection. Thromboelastogram parameters remained normal or supranormal for all patients at all time points. One incident of post-hepatectomy haemorrhage occurred, despite a normal coagulation profile. Two patients suffered late pulmonary embolic episodes. Post liver resection haemostasis is complex and poorly reflected by INR, which should not guide initiation of chemical thromboprophylaxis in the immediate post-operative period.

Sections du résumé

BACKGROUND
International normalized ratio (INR) is used as a marker of the haemostatic status following liver resection. However, the impact of liver resection on haemostasis is complex and beyond what can be measured by INR. This study aimed to prospectively assess haemostatic profile following liver resection and determine if INR measurement can safely guide post-operative thromboprophylaxis.
METHODS
In this prospective cohort study, patients undergoing liver resection had coagulation parameters (International normalised ratio (INR), prothrombin time (PT), activated partial thromboplastin time, fibrinogen, d-dimer, von Willebrand factor antigen, procoagulant activity of phospholipids and clotting factors II, VII, VIIIc, IX and X) and thromboelastogram parameters assessed perioperatively. Clinical follow-up assessed for thromboembolism and haemorrhage.
RESULTS
In the 41 patients included, INR was significantly (P < 0.0001) elevated post-operatively, and INR >1.5 was observed in seven of 41 (17.1%) on post-operative day 1 and one of 41 (2.4%) patients on post-operative day 3, respectively. Factor VII levels showed transient reduction but other factors, especially factors II and X, remained within normal range following liver resection. Thromboelastogram parameters remained normal or supranormal for all patients at all time points. One incident of post-hepatectomy haemorrhage occurred, despite a normal coagulation profile. Two patients suffered late pulmonary embolic episodes.
CONCLUSION
Post liver resection haemostasis is complex and poorly reflected by INR, which should not guide initiation of chemical thromboprophylaxis in the immediate post-operative period.

Identifiants

pubmed: 32455509
doi: 10.1111/ans.15912
doi:

Substances chimiques

Anticoagulants 0
Hemostatics 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1112-1118

Informations de copyright

© 2020 Royal Australasian College of Surgeons.

Références

Siu J, McCall J, Connor S. Systematic review of pathophysiological changes following hepatic resection. HPB 2014; 16: 407-21.
Baltatzis M, Low R, Stathakis P, Sheen AJ, Siriwardena AK, Jamdar S. Efficacy and safety of pharmacological venous thromboembolism prophylaxis following liver resection: a systematic review and meta-analysis. HPB 2017; 19: 289-96.
Russell MC. Complications following hepatectomy. Surg. Oncol. Clin. N. Am. 2015; 24: 73-96.
Wrighton LJ, O'Bosky KR, Namm JP, Senthil M. Postoperative management after hepatic resection. J. Gastrointest. Oncol. 2012; 3: 41-7.
Ramsay MAE, Trotter JF. The INR is only one side of the coagulation cascade: time to watch the clot. Anaesthesia 2016; 71: 613-7.
Nathan H, Weiss MJ, Soff GA et al. Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. J. Gastrointest. Surg. 2014; 18: 295-303.
Weiss MJ, Kim Y, Ejaz A et al. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB 2014; 16: 892-8.
Barton JS, Riha GM, Differding JA et al. Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB 2013; 15: 865-71.
Melloul E, Dondéro F, Vilgrain V, Raptis DA, Paugam-Burtz C, Belghiti J. Pulmonary embolism after elective liver resection: a prospective analysis of risk factors. J. Hepatol. 2012; 57: 1268-75.
Reddy SK, Turley RS, Barbas AS et al. Post-operative pharmacologic thromboprophylaxis after major hepatectomy. J. Gastrointest. Surg. 2011; 15: 1602-10.
Tzeng C-WD, Katz MHG, Fleming JB et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB 2012; 14: 506-13.
Strasberg SM, Belghiti J, Clavien PA et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2: 333-9.
Birgin E, Tesfazgi W, Knoth M, Wilhelm TJ, Post S, Ruckert F. Evaluation of the new ISGLS definitions of typical posthepatectomy complications. Scand. J. Surg. 2019; 108: 130-6.
Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS. An update of consensus guidelines for warfarin reversal. Med. J. Aust. 2013; 198: 198-9.
Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J. Anaesth. 2014; 58: 515-23.
Chahal R, Alexander M, Yee K et al. Impact of a risk-stratified thromboprophylaxis protocol on the incidence of postoperative venous thromboembolism and bleeding. Anaesthesia. 2020. http://doi.org/10.1111/anae.15077
Gale AJ. Continuing education course #2: current understanding of hemostasis. Toxicol. Pathol. 2011; 39: 273-80.
Roberts HR, Cederbaum AI. The liver and blood coagulation: physiology and pathology. Gastroenterology 1972; 63: 297-320.
Cerutti E, Stratta C, Romagnoli R et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl. 2004; 10: 289-94.
Ejaz A, Spolverato G, Kim Y et al. Defining incidence and risk factors of venous thromboembolism after hepatectomy. J. Gastrointest. Surg. 2014; 18: 1116-24.
Burbury KL, Milner A, Snooks B, Jupe D, Westerman DA. Short-term warfarin reversal for elective surgery - using low-dose intravenous vitamin K: safe, reliable and convenient*. Br. J. Haematol. 2011; 154: 626-34.
Liontos L, Fralick M, Longmore A, Hicks LK, Sholzberg M. Bleeding risk using INR/aPTT pre-surgery: systematic review (BRUISR) (BRUISR). Blood 2017; 130 (Suppl. 1): 4654.
Favaloro EJ, Lippi G. Coagulation update: what's new in hemostasis testing? Thromb. Res. 2011; 127 (Suppl. 2): S13-6.
Mallett SV, Sugavanam A, Krzanicki DA et al. Alterations in coagulation following major liver resection. Anaesthesia 2016; 71: 657-68.
Potze W, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing. Aliment. Pharmacol. Ther. 2015; 41: 189-98.
Groeneveld DJ, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy. Br. J. Surg. 2016; 103: 735-43.

Auteurs

June Oo (J)

Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Megan Allen (M)

Department of Anaesthesia, Perioperative and Pain Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Centre for Integrated Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.

Benjamin P T Loveday (BPT)

Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Department of Surgery, The University of Auckland, Auckland, New Zealand.
Department of General Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Nora Lee (N)

Department of Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Brett Knowles (B)

Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Department of General Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Bernhard Riedel (B)

Department of Anaesthesia, Perioperative and Pain Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Centre for Integrated Critical Care, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.

Kate Burbury (K)

Department of Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.

Benjamin Thomson (B)

Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
University of Melbourne Department of Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH